Introduction
Spondylometaphyseal dysplasias have been classified by Maroteaux and Spranger (1991) as well as by Duetting et al. (1998) based on severity of the changes in the femoral neck and metaphyses as well as vertebral abnormalities. SMD type A4 (SMDTA4) is characterized by severe changes of the femoral neck, marked metaphyseal abnormalities and ovoid, flattened vertebral bodies with an anterior tongue-like deformity (Maroteaux and Spranger 1991; Duetting et al. 1998). In addition to classical SMDTA4 characteristics, our patient has progressive scoliosis and lack of ossification of the capital femoral epiphyses at the age of 11 years. A genetic defect that cause SMDTA4 is so far unknown.
The Jansen type of SMD reported by Campbell et al. (2000), which is a phenotypic variant of Jansen metaphyseal chondrodysplasia, shares similar phenotypic features with our patient (Table 1). We decided to analyze the PTHR1 gene encoding PTH/PTHrP receptor for parathyroid hormone related peptide (PTHrP) and parathyroid hormone (PTH), since mutations in this gene are a known cause of Jansen metaphyseal chondrodysplasia (Schipani et al. 1999).
Case report
The patient is a Caucasian female (Fig. 1), who was born to a 32-year-old mother and 34-year-old father after a third full term uneventful pregnancy. Her birth weight was 2700g, length 40 cm, head circumference 35 cm. The patient has two healthy half-siblings from the mother’s first marriage. Analysis of the family history did not reveal previous bone disorders in the other family members. Bone dysplasia was considered as a diagnosis due to the short stature of the newborn, however, no radiographs were taken at that time. The patient’s motor development was delayed; she started to walk at the age of 2 years. At the age of 3 years she was referred to the Ambulant Centre for Defects of Locomotor Apparatus in Prague. At that time her height was 62 cm (-8.8 SD), upper segment/lower segment = 39.7 cm (-.5 SD)/22.3 cm (-10.1 SD), arm span 63 cm, head circumference 48.6 cm (between 25-50 centile) and her weight was 8 kg. The patient had a genu valgum deformity and a waddling gait was observed. Her hands and feet were relatively long.
At the age of 4 years, patient was able to walk only for short distances. At that time she developed recurrent paroxysmal attacks of impaired consciousness with succession of muscular spasms. The cause of her seizures was hypertension secondary to a right dysplastic kidney. After right nefrectomy, her seizures disappeared and the blood pressure returned to normal. Bracing was used as a treatment for patient’s severe scoliosis at the age of 4 years.
Radiographs taken between 2 and 6.5 years documented lack of ossification of the capital femoral epiphyses, severe metaphyseal changes, scoliosis convex to the left, and delayed carpal/tarsal bone age (Fig. 2a-d).
At 6.5 years her height was 72 cm (-9.2 SD) and her weight was 11 kg. The patient’s thickness of skin folds was normal and her muscle development correlated with the length of her extremities. Her mental development, vision and hearing were normal.
At the age of 9 years the patient’s height was 78.8 cm (-9.2 SD), the upper segment/lower segment ratio was 47 cm(-10.2 SD)/31.8 cm(-9.4 SD), span 86 cm, weight 13.3 kg and the head circumference 51.6 cm (33rd centile).
At 10 years her height was 80 cm (-10 SD) and her weight was 14.5 kg (Fig. 1). There was an increase of her spinal deformity (dextro-convex scoliosis of the thoracic spine and sinistro-convex scoliosis of the thoraco-lumbar spine with marked hyperextension), (Fig. 1). Her mobility was limited; she was walking by taking short steps.
Radiographs taken between 6.5 and 11 years of age documented progress of spinal scoliosis and increased genu valgum deformity. Ossification of the capital femoral epiphyses was absent and the carpal/tarsal bone age was delayed (Fig. 3a-g). Bilateral release of tractus iliotibialis and osteotomy of the left fibula, with corrective osteotomy of proximal metaphyses of the left tibia, were performed at the age of 8.5 years. At 9.5 years of age bilateral partial medial epiphyseodesis of distal femora was performed. Valgus deformity of the knees decreased after these surgeries.
Methods and results
The laboratory tests showed normal routine blood and urine examinations. The serum levels of Ca, P and total alkaline phosphatase were normal as were the markers of bone turnover (bone alkaline phosphatase, osteocalcine and CTX – carboxyl-terminal telopeptide of collagen type I) and parathyroid hormone.
The patient had a normal karyotype (46,XX). Analysis of three regions of four common mutations (H223R, T410P, T410R, and I458R) in the PTHR1 gene, did not reveal any changes in the sequence of this gene (Schipani et al. 1999; Bastepe et al. 2004). Analysis of the PTHR1 gene was limited only to exons 7, 12 and 13 where the frequently mutated codons 223, 410 and 458 are located. Exons 7 and 12 were amplified by PCR with primers published by Czarny-Ratajczak et al. (2009). The following primers were used for amplification of exon 13 of the PTHR1 gene: F5’-GGCAAGTCCAGATGCACTATG-3’ and R5’-GGAGGAACAAAGAAATAACAGG-3’. Sequencing of all PCR products was carried out directly using a dGTP BigDyeTM Terminator v3.0 Ready Reaction Cycle Sequencing Kit and an ABI Prism 3100 Sequencer (Applied Biosystems, Foster City, CA).
We detected via densitometry (DXA) low bone mineral density at the lumbar spine and at the whole body. Z-scores of our patient adjusted for age, sex and body size were less than -2.0.
Discussion
We reviewed the literature and found no cases that fully resembled our patient who shares most phenotypic similarities with SMDTA4 patients described by Maroteaux and Spranger (1991), Duetting et al. (1998) as well as a patient reported by Campbell et al. (2000). Maroteaux and Spranger (1991) classified SMD accordingly to the femoral neck involvement, severity of metaphyseal changes and spinal abnormalities. SMDTA4 was mentioned in the classification of Maroteaux and Spranger (1991), however, without a detailed description.
Unlike other SMDTA4 patients reported in the literature, our patient has distinctive phenotypic features: short stature, congenital progressive scoliosis and progressive genu valgum deformity (Fig. 1). The radiographic changes include severe femoral neck involvement with absence of ossification of the capital femoral epiphyses at the age of 11 years, severe dysplasia of the knees with progressive valgus deformity and delayed carpal bone age (Figs. 2a-d and 3a-g). Lack of ossification of capital femoral epiphyses as well as progressive scoliosis have not been reported in SMDTA4. The carpal/epiphyseal dissociation with predominant involvement of the proximal carpal row observed in our patient was also noted in the second patient reported by Duetting et al. (1998). The patient presented by Campbell et al. (2000) as Jansen type of spondylometaphyseal dysplasia, also shares phenotypic features with our patient (Table 1). All other publications on SMD (Czarny-Ratajczak et al. 2009; Dieux-Coeslier et al. 2004; Goldblatt et al. 1991; Gustavson et al. 1978; Kozlowski et al. 1988; Kozlowski et al. 1976; Peeden et al. 1992; Shebib et al. 1991; Walters et al. 2004), characterize patients with phenotypes other than that of our patient, and a different pattern and severity of radiographic changes. The variety of SMD forms is most likely the consequence of mutations in different genes that are involved in cartilage development. Spondylometaphyseal dysplasias as well as spondyloepimetaphyseal dysplasias are very heterogeneous groups of bone dysplasias still explored at the molecular level, which in familial cases, frequently leads to identification of new candidate genes for these disorders. The unknown molecular background of SMDTA4 and lack of affected family members significantly limits the diagnostic options for sporadic patients with rare forms of SMD.
References
Bastepe M, Raas-Rothschild A, Silver J, Weissman I, Wientroub S, Juppner H, Gillis D (2004) A form of Jansen’s metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation. J Clin Endocrinol Metab 89:3595–3600. doi:10.1210/jc.2004-0036
Campbell JB, Kozlowski K, Lejman T, Sulko J (2000) Jansen type of spondylometaphyseal dysplasia. Skeletal Radiol 29:239–242. doi:10.1007/s002560050601
Czarny-Ratajczak M, Chrzanowska K, Bieganski T, Sulko J, Baranska D, Kocyla-Karczmarewicz E, Kuszel L, Jakubowski L, Niedzielski K, Kozlowski K (2009) Severe neonatal spondylometaphyseal dysplasia in two siblings. Am J Med Genet A 149A(10):2166–2172. doi:10.1002/ajmg.a.33016
Dieux-Coeslier A, Moerman A, Holder M, Boute O, Maroteaux P, Manouvrier S, Le Merrer M (2004) Metaphyseal chondrodysplasia with cone-shaped epiphyses: a specific form involving the lower limbs. Am J Med Genet A 124A(1):60–66. doi:10.1002/ajmg.a.20411
Duetting T, Schulze A, Troeger J, Spranger J (1998) A rare form of spondylometaphyseal dysplasia-type A4. Am J Med Genet 78:61–66. doi:10.1002/(SICI)1096-8628(19980616)78:1<61::AID-AJMG13>3.0.CO;2-M
Goldblatt J, Carman P, Sprague P (1991) Unique dwarfing, spondylometaphyseal skeletal dysplasia, with joint laxity and dentinogenesis imperfecta. Am J Med Genet 39:170–172. doi:10.1002/ajmg.1320390211
Gustavson KG, Holmgren G, Probst F (1978) Spondylometaphyseal dysplasia in two sibs of normal parents. Pediat Radiol 7:90–96. doi:10.1007/BF00975677
Kozlowski K, Bacha L, Massen R, Ayati M, Sator S, Brahimi L (1988) A new type of spondylometaphyseal dysplasia – algerian type. Report of five cases. Pediat Radiol 18:221–226. doi:10.1007/BF02390399
Kozlowski K, Barylak A, Middleton RW, Rybakowa M, Thomas P, Walecki J (1976) Spondylometaphyseal dysplasias (Report of case of common type and three pairs of siblings of new varieties). Aust Radiol 20:154–161. doi:10.1111/j.1440-1673.1976.tb02013.x
Maroteaux P, Spranger J (1991) The spondylometaphyseal dysplasias. A tentative classification. Pediatr Radiol 21:293–297. doi:10.1007/BF02018629
Peeden JN Jr, Rimoin DL, Lachman RS, Dyer ML, Gerard D, Gruber HE (1992) Spondylometaphyseal dysplasia, sedaghatian type. Am J Med Genet 44:651–656. doi:10.1002/ajmg.1320440525
Shebib SM, Chudley AE, Reed MH (1991) Spondylometaphyseal dysplasia congenita, Strudwick type. Pediatr Radiol 21:298–300. doi:10.1007/BF02018630
Schipani E, Langman C, Hunzelman J, Le Merrer M, Loke KY, Dillon MJ, Silve C, Juppner H (1999) A novel parathyroid hormone (PTH)/PTH related peptide receptor mutations in Jansen-type metaphyseal chondrodysplasia. J Clin Endocrinol Metab 84:3052–3057. doi:10.1210/jc.84.9.3052
Walters BA, Raff ML, Ver Hoeve J, Tesser R, Langer LO, France TD, Glass IA, Pauli RM (2004) Spondylometaphyseal dysplasia with cone-rod dystrophy. Am J Med Genet A 129A(3):265–276. doi:10.1002/ajmg.a.30145
Ethical standards
Analysis of the reported patient was approved by the local ethical committee and a written informed consent was obtained from patient’s legal guardians.
Conflict of interests
The authors declare that they have no conflict of interest.
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Marik, I., Hudakova, O., Petrasova, S. et al. A new form or a variant of SMD type A4. J Appl Genetics 53, 289–294 (2012). https://doi.org/10.1007/s13353-012-0094-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13353-012-0094-0